NO20072060L - 2-acylaminotiazolderivater - Google Patents
2-acylaminotiazolderivaterInfo
- Publication number
- NO20072060L NO20072060L NO20072060A NO20072060A NO20072060L NO 20072060 L NO20072060 L NO 20072060L NO 20072060 A NO20072060 A NO 20072060A NO 20072060 A NO20072060 A NO 20072060A NO 20072060 L NO20072060 L NO 20072060L
- Authority
- NO
- Norway
- Prior art keywords
- acylaminotiazolderivater
- compounds
- receptor
- implicated
- neurological
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61223604P | 2004-09-22 | 2004-09-22 | |
| DKPA200401441 | 2004-09-22 | ||
| PCT/DK2005/000591 WO2006032273A1 (fr) | 2004-09-22 | 2005-09-20 | Derives de 2-acylaminothiazole |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20072060L true NO20072060L (no) | 2007-04-23 |
Family
ID=35169521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20072060A NO20072060L (no) | 2004-09-22 | 2007-04-23 | 2-acylaminotiazolderivater |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7910613B2 (fr) |
| EP (1) | EP1794157B1 (fr) |
| AU (1) | AU2005287729A1 (fr) |
| CA (1) | CA2581105A1 (fr) |
| EA (1) | EA200700707A1 (fr) |
| MX (1) | MX2007003381A (fr) |
| NO (1) | NO20072060L (fr) |
| WO (1) | WO2006032273A1 (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI3002283T1 (en) | 2003-12-26 | 2018-06-29 | Kyowa Hakko Kirin Co., Ltd. | Thiazole derivatives |
| US7674912B2 (en) | 2005-04-25 | 2010-03-09 | H. Lundbeck A/S | Pro-drugs of N-thiazol-2-yl-benzamide derivatives |
| WO2006137527A1 (fr) * | 2005-06-23 | 2006-12-28 | Kyowa Hakko Kogyo Co., Ltd. | Dérivé du thiazole |
| LT1921077T (lt) | 2005-08-02 | 2017-09-25 | Kyowa Hakko Kirin Co., Ltd. | Agentas, skirtas miego sutrikimo gydymui ir (arba) prevencijai |
| TWI473614B (zh) * | 2008-05-29 | 2015-02-21 | Kyowa Hakko Kirin Co Ltd | Anti-analgesic inhibitors |
| ES2658892T3 (es) * | 2008-07-23 | 2018-03-12 | Kyowa Hakko Kirin Co., Ltd. | Agente terapéutico para la migraña |
| TWI548411B (zh) * | 2009-04-28 | 2016-09-11 | Kyowa Hakko Kirin Co Ltd | Exercise disorder treatment |
| WO2018166855A1 (fr) | 2017-03-16 | 2018-09-20 | Basf Se | Dihydroisoxazoles à substitution hétérobicyclique |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE855120C (de) | 1950-10-08 | 1953-01-05 | Schering Ag | Verfahren zur Herstellung von Aminosalicylsaeureamiden |
| CA2020437A1 (fr) | 1989-07-05 | 1991-01-06 | Yoshihide Fuse | Derive de cinnamamide |
| JP2903339B2 (ja) | 1990-10-12 | 1999-06-07 | 大日精化工業株式会社 | 電子写真感光体 |
| DK0870765T3 (da) | 1995-05-18 | 2004-02-23 | Zeria Pharm Co Ltd | Aminothiazolderivat, lægemiddel indeholdende samme og mellemprodukt til fremstilling af forbindelsen |
| TW513418B (en) * | 1996-07-31 | 2002-12-11 | Otsuka Pharma Co Ltd | Thiazole derivatives, their production and use |
| US6121301A (en) | 1996-10-24 | 2000-09-19 | Zeria Pharmaceutical Co., Ltd. | Substituted benzoylaminothiazole derivatives and drugs containing the same |
| WO1999064418A1 (fr) | 1998-06-05 | 1999-12-16 | Novartis Ag | Aryl-pyridinyl-thiazoles |
| GB9823871D0 (en) | 1998-10-30 | 1998-12-23 | Pharmacia & Upjohn Spa | 2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents |
| DE60020226T2 (de) | 1999-03-10 | 2006-02-02 | Shionogi & Co., Ltd. | Medizinische zubereitungen mit [2.2.1] und [3.1.1]bicycloskelett die antagonisten für sowohl pgd 2? als auch txa 2? rezeptoren sind |
| ES2391550T3 (es) | 1999-04-15 | 2012-11-27 | Bristol-Myers Squibb Company | Inhibidores cíclicos de la proteína tirosina quinasa |
| US7125875B2 (en) | 1999-04-15 | 2006-10-24 | Bristol-Myers Squibb Company | Cyclic protein tyrosine kinase inhibitors |
| FR2796643B1 (fr) * | 1999-07-22 | 2005-04-29 | Sod Conseils Rech Applic | Derives de 2-arylimino-2, 3-dihydrothiazoles, leurs procedes de preparation et leur utilisation therapeutique |
| EP1295872A4 (fr) | 2000-06-02 | 2007-05-16 | Shionogi & Co | Composition medicamenteuse antagoniste pour les recepteurs de pgd2/txa2 |
| GB0028383D0 (en) | 2000-11-21 | 2001-01-03 | Novartis Ag | Organic compounds |
| GB0100624D0 (en) | 2001-01-10 | 2001-02-21 | Vernalis Res Ltd | Chemical compounds VII |
| WO2002059100A1 (fr) | 2001-01-26 | 2002-08-01 | Shionogi & Co., Ltd. | Composes halogene ayant un agonisme envers le recepteur de thrombopoietine |
| US7429593B2 (en) | 2001-09-14 | 2008-09-30 | Shionogi & Co., Ltd. | Utilities of amide compounds |
| US6624163B2 (en) | 2001-11-29 | 2003-09-23 | Hoffman-La Roche Inc. | Benzothiazole derivatives |
| US6713499B2 (en) | 2001-12-12 | 2004-03-30 | Hoffman-La Roche Inc. | 7-Amino-benzothiazole derivatives |
| US20050043315A1 (en) | 2002-01-02 | 2005-02-24 | Hideo Tsutsumi | Aminopyrimidine compounds, processes for their preparation and pharmaceutical compositions containing them |
| US20040209930A1 (en) | 2002-10-02 | 2004-10-21 | Carboni Joan M. | Synergistic methods and compositions for treating cancer |
| DE60335294D1 (de) | 2002-12-19 | 2011-01-20 | Schering Corp | Dlung des extrapyramidalen syndroms |
| DE10348022A1 (de) | 2003-10-15 | 2005-05-25 | Imtm Gmbh | Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen |
| TW200524887A (en) | 2003-10-27 | 2005-08-01 | Lundbeck & Co As H | N-thiazol-2-yl-benzamide derivatives |
| SI3002283T1 (en) | 2003-12-26 | 2018-06-29 | Kyowa Hakko Kirin Co., Ltd. | Thiazole derivatives |
| EA017262B1 (ru) | 2004-09-02 | 2012-11-30 | Дженентек, Инк. | Соединения 2-(2-галоген-4-аминофенил)пиридиновых ингибиторов передачи сигналов белком hedgehog (варианты), способ их получения, композиция и способы лечения рака и ингибирований ангиогенеза и сигнального пути hedgehog в клетках на их основе |
| WO2006051704A1 (fr) | 2004-11-15 | 2006-05-18 | Taisho Pharmaceutical Co., Ltd. | Composé imine |
| US7674912B2 (en) | 2005-04-25 | 2010-03-09 | H. Lundbeck A/S | Pro-drugs of N-thiazol-2-yl-benzamide derivatives |
| LT1921077T (lt) | 2005-08-02 | 2017-09-25 | Kyowa Hakko Kirin Co., Ltd. | Agentas, skirtas miego sutrikimo gydymui ir (arba) prevencijai |
| WO2007022415A2 (fr) | 2005-08-18 | 2007-02-22 | Pharmacopeia, Inc. | 2-aminothiazoles substitues pour le traitement de maladies neurodegeneratives |
-
2005
- 2005-09-20 CA CA002581105A patent/CA2581105A1/fr not_active Abandoned
- 2005-09-20 US US11/663,054 patent/US7910613B2/en not_active Expired - Fee Related
- 2005-09-20 MX MX2007003381A patent/MX2007003381A/es active IP Right Grant
- 2005-09-20 AU AU2005287729A patent/AU2005287729A1/en not_active Abandoned
- 2005-09-20 WO PCT/DK2005/000591 patent/WO2006032273A1/fr active Application Filing
- 2005-09-20 EP EP05784170.2A patent/EP1794157B1/fr active Active
- 2005-09-20 EA EA200700707A patent/EA200700707A1/ru unknown
-
2007
- 2007-04-23 NO NO20072060A patent/NO20072060L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2581105A1 (fr) | 2006-03-30 |
| MX2007003381A (es) | 2007-04-27 |
| EP1794157B1 (fr) | 2014-02-26 |
| US20090137642A1 (en) | 2009-05-28 |
| US7910613B2 (en) | 2011-03-22 |
| EA200700707A1 (ru) | 2007-08-31 |
| AU2005287729A1 (en) | 2006-03-30 |
| EP1794157A1 (fr) | 2007-06-13 |
| WO2006032273A1 (fr) | 2006-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20072060L (no) | 2-acylaminotiazolderivater | |
| NO20052796L (no) | Indolylpyrazinonderivater anvendelige for behandling av hyper-proliferative forstyrrelser og sykdommer assosiert med angiogenese | |
| MX2007000505A (es) | Derivados de oxindol sustituidos y medicamentos que contienen los mismos. | |
| EP1740581A4 (fr) | Composes derives de pyridyle substitues aux positions 2, 4, 6 utiles comme inhibiteurs de la beta-secretase dans le traitement de la maladie d'alzheimer | |
| NO20062417L (no) | N-tiazol-2-yl-benzamidderivater | |
| IL174210A0 (en) | 1,4 disubstituted isoquinilone derivatives as raf-kinase inhibitors useful for the treatment of proliferative diseases | |
| NO20060324L (no) | [1,8]Naftyridin-2-oner og relaterte forbindelser for behandling av Schizofreni | |
| UA92503C2 (ru) | Соединения 5-(фенилизоксазолилэтокси)-триазол-3-ил-замещенного пиридина для лечения неврологических, психиатрических или болевых расстройств | |
| CY1107956T1 (el) | Χρηση υποκατεστημενων 2-αμινοτετραλινιων για την προληπτικη αντιμετωπιση της νοσου του παρκινσον | |
| NO20070606L (no) | Inhibitorer av IAP | |
| NO20071719L (no) | Pyridylinhibitorer for "hedgehog"-signalisering | |
| NO20082136L (no) | 1,5-substituerte indol-2-yl-amidderivater | |
| DE602004022668D1 (de) | 5-gliedrige heterocyclische p-38 inhibitoren | |
| MY135841A (en) | Novel benzodioxoles | |
| DK2194053T3 (da) | Methoxypiperidinderivater til brug i behandling af gastrointestinale forstyrrelser og forstyrrelser i centralnervesystemet. | |
| NO20032801L (no) | Tiazolderivater for behandling av PPAR-relaterte forstyrrelser | |
| TW200635903A (en) | Therapeutic agents | |
| NO20062256L (no) | Hydroksyalkylsubstituerte pyrido-7-pyrimidin-7-oner | |
| NO20082096L (no) | Azaindol-2-karboksamidderivativer | |
| NO20061137L (no) | Cyklopropylderivater som NK3-reseptorantagonister | |
| EP1817311A4 (fr) | Derives pyridyle 2,3,4,6-substitues utiles comme inhibiteurs de la beta-secretase pour le traitement de la maladie d'alzheimer | |
| TW200633986A (en) | Therapeutic agents | |
| TW200503710A (en) | Novel compounds | |
| TW200634013A (en) | Quinoline derivative, its use, production and pharmaceutical agents containing the derivative | |
| NO20071574L (no) | Arylsulfonylstilbenderivater for behandling av insomni og beslektede tilstander. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CREP | Change of representative |
Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104 |
|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |